CME Activity: Recognizing Cutaneous Squamous Cell Carcinoma in Primary Care

Start Date: April 1, 2019

Expiration Date: March 31, 2020

Target Audience: Primary Care Physicians, Nurse Practitioners, Physician Assistants

Format: Case-based learning

Estimated Time to Complete: 0.5 hours

Sponsored and Certified By:

National Association for Continuing Education


AMA accreditation statement

The National Association for Continuing Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education and Figure 1.


AANP accreditation statement

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 0.5 contact hours of continuing education.


How to Obtain your CME Certificate:

1. View the CME activity.

2. Complete the post-test. You must score at least 75% on the post-test to claim credit.

3. Complete the evaluation.

4. Receive email with your CME certificate.


Needs Assessment:

“Nonmelanoma skin cancer and actinic keratoses may be partially preventable by physician counseling...[yet] physicians provide skin cancer prevention counseling or education at fewer than half of visits for high-risk patients (1).” In addition, “patients with SCC on chronic lesions are at increased risk of metastasis and recurrence (2).” It is critical that physicians recognize this risk, and appropriately examine and counsel patients. Primary care practitioners (PCPs) can benefit from learning how to better recognize the risks and clinical features of cutaneous squamous cell carcinoma (SCC) to ensure timely and accurate management.

Feldman SR et al. Skin examinations and skin cancer prevention counseling by US physicians: a long way to go. J Am Acad Dermatol. 2000;43:234-7

Renzi C et al. Delay in diagnosis and treatment of squamous cell carcinoma of the skin. Acta Derm Venereol. 2010;90(6):595-601


Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Describe the U.S. Preventive Services Task Force (USPSTF) recommendations for skin cancer screening.

  • Recognize the elevated risk for squamous cell carcinoma in immunocompromised patients.

  • Recognize when to refer patients to a specialist.

  • Describe the baseline risks of metastatic squamous cell carcinoma.

  • It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed.


Faculty disclosures:

  1. Josh Landy, MD, Internal Medicine Physician and Critical Care Specialist, Toronto, ON. No relationships to disclose.

  2. Sharon Vorona, MBBS, Toronto, ON. No relationships to disclose.

  3. Samantha Sexton, MPC, Figure 1 Communications Manager, Toronto, ON. No relationships to disclose.


No commercial support was provided for this CME activity.

ABOUT FIGURE 1
LEGAL
HOW  FIGURE 1 WORKS
PRESS